Man Group plc - ADAPTIVE BIOTECHNOLOGIES COR ownership

ADAPTIVE BIOTECHNOLOGIES COR's ticker is ADPT and the CUSIP is 00650F109. A total of 209 filers reported holding ADAPTIVE BIOTECHNOLOGIES COR in Q2 2023. The put-call ratio across all filers is 0.55 and the average weighting 0.1%.

Quarter-by-quarter ownership
Man Group plc ownership history of ADAPTIVE BIOTECHNOLOGIES COR
ValueSharesWeighting
Q3 2023$646,054
-21.4%
118,542
-3.2%
0.00%
-33.3%
Q2 2023$822,029
-13.0%
122,508
+14.5%
0.00%0.0%
Q1 2023$945,154
+31.9%
107,039
+14.2%
0.00%0.0%
Q4 2022$716,357
-34.3%
93,764
-38.7%
0.00%
-40.0%
Q3 2022$1,090,000
-20.7%
153,051
-10.0%
0.01%
-16.7%
Q2 2022$1,375,000
+10.4%
169,966
+89.5%
0.01%
+50.0%
Q1 2022$1,245,000
-45.6%
89,698
+9.9%
0.00%
-42.9%
Q4 2021$2,290,000
-38.0%
81,596
-24.8%
0.01%
-46.2%
Q3 2021$3,691,000
-17.1%
108,577
-0.3%
0.01%
-18.8%
Q2 2021$4,451,000
-23.6%
108,941
-24.7%
0.02%
-38.5%
Q1 2021$5,827,000
-30.5%
144,735
+2.1%
0.03%
-29.7%
Q4 2020$8,379,000
+18.8%
141,706
-2.3%
0.04%
+32.1%
Q3 2020$7,056,000
-6.9%
145,104
-7.4%
0.03%
-26.3%
Q2 2020$7,578,000
+1120.3%
156,631
+601.0%
0.04%
+850.0%
Q1 2020$621,000
-95.2%
22,343
-94.8%
0.00%
-90.5%
Q4 2019$12,889,000
+579.1%
430,809
+601.5%
0.04%
+500.0%
Q3 2019$1,898,00061,4120.01%
Other shareholders
ADAPTIVE BIOTECHNOLOGIES COR shareholders Q2 2023
NameSharesValueWeighting ↓
Blue Water Life Science Advisors, LP 3,030,434$23,152,51615.55%
BERYLSON CAPITAL PARTNERS, LLC 289,726$2,213,5076.45%
Matrix Capital Management Company, LP 11,572,590$88,414,5881.69%
Pier Capital, LLC 1,012,401$7,734,7441.27%
VIKING GLOBAL INVESTORS LP 29,993,708$229,151,9291.15%
Eagle Health Investments LP 607,860$4,644,0501.07%
Triatomic Management LP 130,805$999,3500.84%
Aristotle Atlantic Partners, LLC 1,880,567$14,367,5320.80%
Senator Investment Group LP 1,000,000$7,640,0000.69%
ARK Investment Management 9,201,245$70,297,5120.61%
View complete list of ADAPTIVE BIOTECHNOLOGIES COR shareholders